Avalo Therapeutics, INC. (AVTX) — DEF 14A Filings
All DEF 14A filings from Avalo Therapeutics, INC.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Avalo Therapeutics Files 2025 Proxy Statement
— May 1, 2025 Risk: low
Avalo Therapeutics, Inc. (AVTX) filed a DEF 14A on May 1, 2025, for the fiscal year ending December 31, 2024. The filing details executive compensation and corp -
Avalo Therapeutics Files 2024 Proxy Statement
— Jun 27, 2024 Risk: low
Avalo Therapeutics, Inc. filed its definitive proxy statement (DEF 14A) on June 27, 2024, for its annual meeting scheduled for August 13, 2024. The filing conce
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX